Blog - Latest News

You are here: Home » General Biotechnology » Drug Patent Expirations in September 2008
September 2, 2008
02 Sep 2008

Drug Patent Expirations in September 2008

Courtesy of DrugPatentWatch.com:

Drug Patent Expirations in September 2008

*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
ANDRODERM Watson Labs testosterone 4,855,294 Sep 6, 2008
AVITA Mylan Bertek tretinoin 5,045,317 Sep 3, 2008
DDAVP Sanofi Aventis Us desmopressin acetate 5,047,398 Sep 10, 2008
OPANA ER Endo Pharms oxymorphone hydrochloride 5,128,143 Sep 19, 2008
RESCULA R Tech Ueno Ltd unoprostone isopropyl 5,001,153 Sep 19, 2008

Courtesy of DrugPatentWatch.com

Tags: , ,
0 Comments/0 Tweets/in General Biotechnology
Related Entries

Drug Patent Expirations in March 2008

Pharmaceutical globalization: Where are drugs...

Discovering potential drug targets

Drug Patent Expirations in December 2008

0 replies
  1. piyush gupta says:
    September 17, 2008 at 7:34 am

    hi nice blog . the latest patent information u have n the books collection on biotechnology u have is good one

    Reply
  2. sanchit says:
    September 21, 2008 at 12:39 pm

    hey thats a best site i have seenso far regarding bio tech…rock on buddy..

    Reply

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Get updates by email


 

BiotechBlog’s Editor

Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.

Read More...

Network and Share

Connect on LinkedIn
Join BiotechBlog on LinkedIn
Follow BiotechBlog on Twitter
Share BiotechBlog on LinkedIn  Tweet BiotechBlog on Twitter Email biotechnology policy, regulation, and law

Categories

Recommended Reading

Image of Great Patents: Advanced Strategies For Innovative Growth Companies
Image of Get to Market Now! Turn FDA Compliance into a Competitive Edge in the Era of Personalized Medicine
Image of Building the Case for Biotechnology: Management Case Studies in Science, Laws, Regulations, Politics, and Business
Image of Biotechnology Entrepreneurship From Science to Solutions -- Start-up, Company Formation and Organization, Team, Intellectual Property, Financing, ... Regulatory Affairs, Reimbursement, Exit
Image of Biotechnology Entrepreneurship Bootcamp: Journal of Commercial Biotechnology Special Issue
Image of The Life Science Innovation Roadmap: Bioscience Innovation Assessment, Planning, Strategy, Execution, and Implementation
Image of Revolutions: Paving the Way for the Bioeconomy
Image of Building Biotechnology: Business, Regulations, Patents, Law, Politics, Science

Translator

© Copyright - BiotechBlog — A thinkBiotech product